Tarsus Pharmaceuticals, Inc. posts $62.09 million annual profit

Tarsus Pharmaceuticals, Inc. [TARS]  has posted annual profit of $62.09 million for the year ended Dec 31,2022.

The company based in California(CA)reported a fellin revenue to $25.82 milion for the year when compared to $57.03 million in the previous year.

A filing from the company with the Securities and Exchange Commission on Mar 17,2023 showed that its revenue is  up 54.73% year-over-year.

The company reported basic earnings per share of $24619700 and diluted earnings per share of $24619700.

Tarsus Pharmaceuticals, Inc. operates in the Biological Products, Except Diagnostic Substances sector.